BOSTON, MA, Nanite Inc. announced an investment from the Cystic Fibrosis Foundation of up to $2 million			
			 Nanite Inc. announced an investment from the Cystic Fibrosis Foundation of up to $2 million to develop gene delivery technologies for the lung. This investment builds on the $6M seed financing recently announced by the company.
				  
				  (c) by Massinvestor, Inc.  For contact info, please check out our 
about page.